Drug Shortage Report for ANDRODERM

Last updated on 2021-09-02 History
Report ID 140514
Drug Identification Number 02239653
Brand name ANDRODERM
Common or Proper name Testosterone
Company Name ALLERGAN INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TESTOSTERONE
Strength(s) 2.5MG
Dosage form(s) PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 60s
ATC code G03BA
ATC description ANDROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-06-21
Actual start date 2021-06-16
Estimated end date 2021-08-31
Actual end date 2021-08-27
Shortage status Resolved
Updated date 2021-09-02
Company comments Androderm 5mg is available
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-09-02 French Compare
v8 2021-09-02 English Compare
v7 2021-08-19 French Compare
v6 2021-08-19 English Compare
v5 2021-06-23 French Compare
v4 2021-06-23 English Compare
v3 2021-06-22 English Compare
v2 2021-06-07 French Compare
v1 2021-06-07 English Compare

Showing 1 to 9 of 9